Records containing: Uterine Leiomyosarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 2 Study Evaluating the Efficacy of Elacestrant in Patients With Estrogen Receptor Positive Uterine Sarcomas
-
CLINICAL_TRIALS study record update · 2026-03-31A Randomized Phase II Study of Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2026-03-10Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in Uterine Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2025-11-25Phase 2 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Gemcitabine Followed by Systemic Adjuvant Chemotherapy With Dacarbazine for Locally Recurrent Uterine Leiomyosarcoma (LMS)
-
CLINICAL_TRIALS study record update · 2024-11-07Combined Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Women With Inadvertently Morcellated Uterine Leiomyosarcoma: a Registry Study From a Tertiary Referral Hospital
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-06Comparison of Operational Outcomes and Long-term Benefits Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
-
CLINICAL_TRIALS study record update · 2019-07-23A Phase II Evaluation of Sunitinib Malate (Sutent®, SU11248, NCI-Supplied Agent , NSC # 736511) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus
-
CLINICAL_TRIALS study record update · 2015-12-22A Pilot Study of Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
-
CLINICAL_TRIALS study record update · 2015-11-18A Phase II Evaluation of Pazopanib in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus
-
CLINICAL_TRIALS study record update · 2015-07-30A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2014-11-21A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2014-01-20A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas